Insulet Corp. (PODD)
241.89
-7.21
(-2.89%)
USD |
NASDAQ |
Feb 20, 16:00
242.33
+0.44
(+0.18%)
After-Hours: 20:00
Insulet Research and Development Expense (Quarterly) : 90.90M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 721.00M |
| Intuitive Surgical, Inc. | 352.90M |
| Tandem Diabetes Care, Inc. | 46.07M |
| Boston Scientific Corp. | 569.00M |
| Stryker Corp. | 380.00M |